DUBLIN--(BUSINESS WIRE)--The "Global Point of Care Diagnostics Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.
The Global Point of Care Diagnostics Market is poised to grow at a CAGR of around 8.2% over the next decade to reach approximately $49.4 billion by 2025
Some of the prominent trends that the market is witnessing include boosting in the adoption of home based healthcare technologies, rapid economic development in the emerging nations and increase in the investments on R&D to develop novel products.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies for the existing players, new entrants and the future investors.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Point of Care Diagnostics Market, By Prescription Mode
5 Point of Care Diagnostics Market, By Product
6 Point of Care Diagnostics Market, By Technology
7 Point of Care Diagnostics Market, By Sample Type
8 Point of Care Diagnostics Market, By End User
9 Point of Care Diagnostics Market, By Geography
10 Key Player Activities
11 Leading Companies
- Enigma Diagnostics
- Medica Corporation
- Abbott Laboratories, Inc.
- Biolytical Laboratories Inc.
- Beacon Biomedical
- F. Hoffmann-La Roche Ag
- Lipid Plus
- Abaxis, Inc.,
- Epitope Diagnostics Inc,
- Exosomes Diagnostics
- Siemens Ag
- Operon Biotech & Healthcare
- Thermofisher Scientific, Inc.
- Medtronic Plc
- Becton Dickinson and Company
- Ophthalmic Instrument Company
For more information about this report visit https://www.researchandmarkets.com/research/r8pbd6/global_point_of.